Did you know the global cloud mining market is expected to cross $7 billion by 2031? That’s huge and it’s growing fast. Recently, something caught everyone’s attention. XRP, one of the top cryptocurrencies, suddenly jumped by 26%. The big question is: Why now?
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
Oil markets are in turmoil in March 2026, and big tech companies are starting to feel the effects. Since the U.S.-Iran war disrupted shipping through the Strait of Hormuz, a passage that carries about 20 % of the world’s oil, prices have surged sharply, at times topping $100 per barrel. This sudden rise isn’t just bad…
Asian shares opened lower on December 15, 2025, after a weak performance on Wall Street. Global markets are connected, so U.S. stock declines often affect Asia. This week, broad selling spilled into the region as investors stayed cautious, watching central bank signals, economic data, and risk factors from the U.S. and China. Asian shares include…
The question on everyone’s mind this year is clear: Will the IRS send out stimulus checks in 2025? With rising living costs, shifting economic policies, and ongoing discussions in Washington, millions of Americans are watching closely for any sign of a new financial relief program. Continue Reading on Meyka This article is available in full…
On November 7, 2025, the Multi-Commodity Exchange of India (MCX) made headlines after reporting a strong 30% year-on-year profit rise in its Q2 FY26 results. This impressive growth has caught the eye of investors and market watchers alike. MCX, India’s largest commodity exchange, plays a key role in trading metals, energy, and agricultural products. Its…
JSW Cement began trading on the stock market with an impressive opening performance. JSW Cement shares debuted on NSE at ₹153.50, beating the IPO price of ₹147 by an immediate gain of 4 per cent; the opening price on BSE was also at ₹153 per share. It’s a big deal for the company, which is…
We saw Natco Pharma’s share price slide after the U.S. Food and Drug Administration (USFDA) raised seven observations at its Hyderabad facility. This isn’t just a small hiccup; regulatory scrutiny from the USFDA often sets off alarm bells for investors. Natco has responded with confidence, saying it will fix the issues. But the market’s reaction…